Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Oncoinvent Publishes Data Explaining Radspherin ® 's Mechanism of Action

Oncoinvent AS
Posted on: 05 Apr 18
Oncoinvent Publishes Data Explaining Radspherin ® 's Mechanism of Action

PR Newswire

STOCKHOLM, April 5, 2018

STOCKHOLM, April 5, 2018 /PRNewswire/ --

Data describing and explaining Radspherin® 's mechanism of action has been published in the Journal of Labelled Compounds and Radiopharmaceuticals. The data further supports and supplements proof-of-principle preclinical data that the company has previously published.

An open access copy of the article can be downloaded from the Oncoinvent Publications webpage.

For further information, please contact::
Jan A. Alfheim,
Chief Executive Officer 
Cell: +47-46-44-00-45                                                                                                 
Email: alfheim@oncoinvent.com

IR enquiries:
Ole Peter Nordby,
Chief Financial Officer 
Cell: +47-41-28-71-79 
Email: nordby@oncoinvent.com

This information was brought to you by Cision http://news.cision.com
http://news.cision.com/oncoinvent-as/r/oncoinvent-publishes-data-explaining-radspherin----s-mechanism-of-action,c2488319

PR Newswire
www.prnewswire.com

Last updated on: 05/04/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.